• Liu Kun, Eun-Seok Shin, Eun Jung Jun, Youngjune Bhak, Scot Garg, Tae-Hyun Kim, Chang-Bae Sohn, Byung Joo Choi, Lin Hui, Song Lin Yuan, Wang Zhi, Jiang Hao, Shi Zhentao, and Tang Qiang.
• Department of Cardiology, Ulsan Medical Center, Ulsan, Korea.
• Yonsei Med. J. 2021 Nov 1; 62 (11): 981-989.

PurposeAlthough drug-coated balloon (DCB) treatment is known to be effective for de novo lesions, the influence of sex on angiographic and clinical outcomes remains unknown. This study aimed to investigate the angiographic and clinical impact of DCB treatment in patients with de novo coronary lesions according to sex.Materials And MethodsA total of 227 patients successfully treated with DCB were retrospectively enrolled and divided into two groups according to sex. The primary endpoint was late lumen loss (LLL) at 6-month angiography, and the secondary endpoint was target vessel failure (TVF), which included cardiac death, target vessel myocardial infarction, target lesion revascularization, and target vessel thrombosis.ResultsThe study enrolled 60 women (26.4%) and 167 men (73.6%). Compared to men, women had a smaller vessel size, larger DCB to reference vessel ratio, and more dissections after DCB treatment (55.0% vs. 37.1%, p=0.016). Women also had a significantly higher LLL compared to men (0.12±0.26 mm vs. 0.02±0.22 mm, p=0.012) at the 6-month follow-up angiography. During a median follow-up of 3.4 years (range 12.7-28.9 months), TVF was similar (women 6.7% vs. men 7.8%, p=0.944). In multivariable analysis, women were independently associated with a higher LLL.ConclusionLLL was higher in women, but there was no difference in TVF between women and men. Based on multivariable analysis, the women sex was an independent predictor of higher LLL (Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion; NCT04619277).© Copyright: Yonsei University College of Medicine 2021.

14 keywords...

hide…